Triple GDP inspections issued for medicine supply chains
The China Food and Drug Administration (CFDA) cracked down on illegal medicine distribution behaviours last year by issuing a round of unannounced inspectionsOver 50 medicine wholesalers received a tranche of three inspections. Numerous violations were identified. The deficiencies appearing at the top included: The failure to store and distribute drugs while tracking their temperature and humidity. Data integrit...
To continue reading this story get free access
Please note: That all fields marked with an asterisk (*) are required.